MedTrace Logo

ST250 as a Therapeutic Option for Head & Neck Reconstruction

NCT06543823 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-05-18

No results posted yet for this study

Summary

To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing

Conditions

  • Tonsillitis

Interventions

DEVICE

SupraTHEL 250

the membrane is placed onto the wound bed and fixed in place by resorbable interrupted sutures

OTHER

Comparator

no membrane is placed onto the wound bed , left bare to heal

Sponsors & Collaborators

  • Alaa Emara

    lead OTHER

Principal Investigators

  • Alaa Emara · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2025-12-31
Completion
2026-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06543823 on ClinicalTrials.gov